(Q44632200)

4 December 2017

The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation (English)

1 reference

4 December 2017

The mechanism of action of docetaxel (Taxotere®) in xenograft models is not limited to bcl-2 phosphorylation (English)

1 reference

Crossref

https://api.crossref.org/works/10.1023/A:1025436307913

25 March 2024

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1023/A:1025436307913

25 March 2024

1 reference

https://api.crossref.org/works/10.1023/A:1025436307913

25 March 2024

author name string

Lisa Ann Kraus

1

1 reference

4 December 2017

Marie Christine Bissery

6

1 reference

4 December 2017

Shanti K. Samuel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578676

25 March 2024

Steven M. Schmid

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578676

25 March 2024

Donald J. Dykes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578676

25 March 2024

William R. Waud

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578676

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14578676

25 March 2024

publication date

1 August 2003

1 reference

Investigational New Drugs

4 December 2017

1 reference

4 December 2017

21

1 reference

4 December 2017

3

1 reference

4 December 2017

259-268

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1025436307913

4 December 2017

0 references

cites work

Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma

1 reference

12 December 2020

Preclinical evaluation of docetaxel (Taxotere).

1 reference

12 December 2020

Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience.

1 reference

12 December 2020

Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia.

1 reference

12 December 2020

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere)

1 reference

12 December 2020

Purification and characterization of the bcl-2 protein

1 reference

12 December 2020

Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins

1 reference

12 December 2020

Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer

1 reference

12 December 2020

Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia

1 reference

12 December 2020

Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma

1 reference

12 December 2020

Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells

1 reference

12 December 2020

Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers

1 reference

12 December 2020

Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel

1 reference

12 December 2020

Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results

1 reference

12 December 2020

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1 reference

12 December 2020

Docetaxel (Taxotere): an effective agent in the management of second-line breast cancer

1 reference

12 December 2020

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

1 reference

12 December 2020

bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs

1 reference

12 December 2020

Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression.

1 reference

12 December 2020

Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity

1 reference

12 December 2020

Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs

1 reference

12 December 2020

Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis

1 reference

12 December 2020

Mathematical analysis of DNA distributions derived from flow microfluorometry

1 reference

12 December 2020

Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance.

1 reference

12 December 2020

BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.

1 reference

12 December 2020

Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.

1 reference

12 December 2020

Sphingosine induces apoptosis in androgen-independent human prostatic carcinoma DU-145 cells by suppression of bcl-X(L) gene expression

1 reference

12 December 2020

Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.

1 reference

12 December 2020

Taxol induces bcl-2 phosphorylation and death of prostate cancer cells

1 reference

12 December 2020

Bcl2 is the guardian of microtubule integrity

1 reference

12 December 2020

Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer

1 reference

12 December 2020

Inactivation of Bcl-2 by phosphorylation

1 reference

12 December 2020

A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2

1 reference

12 December 2020

Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli.

1 reference

12 December 2020

Comparative effects of taxol and Taxotere on two different human carcinoma cell lines

1 reference

12 December 2020

Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes

1 reference

12 December 2020

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas

1 reference

12 December 2020

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts

1 reference

12 December 2020

Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins

1 reference

12 December 2020

The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation

1 reference

12 December 2020

Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice

1 reference

12 December 2020

Mechanisms of action of taxanes in prostate cancer.

1 reference

12 December 2020

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl‐2 oncoprotein

1 reference

12 December 2020

Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma

1 reference

12 December 2020

Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster

1 reference

12 December 2020

The effect of androgen deprivation on malignant and benign prostate tissue

1 reference

12 December 2020

Cancer chemotherapy reports

40

52

345

DP Griswold

1968

1 reference

Crossref

https://api.crossref.org/works/10.1023/A:1025436307913

Journal of Experimental Therapeutics & Oncology

25 March 2024

44

1

322

P Pantazis

1996

1 reference

Crossref

https://api.crossref.org/works/10.1023/A:1025436307913

25 March 2024

Identifiers

1 reference

Dimensions Publication ID

4 December 2017

0 references

1 reference